|
|
|
More About
|
|
the TrialAdvance Difference |
|
|
|
|
|
|
|
We believe that strengthening the sites’ ability to perform from within — leveraging their existing capabilities — will unify and streamline the clinical trial process. |
|
|
|
Our Unique Approach
|
|
TrialAdvance provides clinical sites with a greater “voice” in translating study demands into actionable success plans. We help sponsors align their needs with the challenges facing sites in the pursuit of trial excellence. In this effort, TrialAdvance is seen as an ally to the sites and a valuable resource to the study team.
|
|
Our approach is different from the practice of layering multiple disparate vendor solutions on sites. These solutions are often seen as additional workload that does not fix the sites’ problems.
|
|
We begin by discovering challenges and deficiencies unique to each site and then formulate action plans, TrialAdvance Engagement-Training™, and accountability measures to meet the study needs.
|
|
What We’re Not — and What We Are |
|
TrialAdvance is not a CRO, a recruitment company, or a media service but rather, the consolidation of that knowledge, experience, and skill set into one company. Our team members have managed study programs for the biopharmaceutical industry; managed operations at investigative sites; and implemented large, centralized recruitment campaigns on the media side.
|
|
We promise customized solutions to fit each unique study challenge. Our consultative approach allows us to work as an extension of the sponsor team — optimizing people, resources, budgets, and time.
|
|
Our expertise helps us address the issues that delay the majority of trials today, including:
• Lack of investigator/site training, support, engagement
• Underperforming clinical trial sites
• Inadequate patient recruitment
• Scarcity of culturally diverse patient populations
|
|
Whether it means early planning for difficult trials or troubleshooting delays in ongoing studies, we help sponsors and sites enhance trial performance. This may involve accelerating patient enrollment, increasing productivity, and/or ensuring adherence to timelines. It may also include developing programs that facilitate communication between CRAs, study teams, and trial sites.
|
|
We specialize in difficult-to-enroll studies, rescue studies, and studies involving special populations such as the elderly, children, women, and diverse racial and ethnic groups.
|
